Portfolio company
ModernVivo
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
ModernVivo develops an AI platform for designing preclinical in vivo studies and finding contract research organisations for pharmaceutical, biotech and academic researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AI VIVO
This systems pharmacology company provides an artificial intelligence platform to accelerate drug discovery and predict clinical efficacy for global pharmaceutical partners.
Meddenovo
This company develops an artificial intelligence platform for de novo cyclic peptide drug discovery to support pharmaceutical and biotechnology firms.
Animol Discovery
This biopharmaceutical company develops small molecule medicines for companion and production animals using artificial intelligence and DNA-encoded library technologies.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
Form Bio
This company provides a software platform using artificial intelligence to help biopharmaceutical organisations and researchers design and optimise cell and gene therapies.
Formation Bio
This company develops in-licensed clinical-stage drug candidates for pharmaceutical and biotechnology partners using a proprietary artificial intelligence platform to accelerate trials.
BenchSci
This company provides an artificial intelligence platform for preclinical research and drug discovery to pharmaceutical companies and academic research institutions.
Bioqore
The company develops AI-driven bioprocessing models and automated wet lab services to optimise drug manufacturing conditions for biotechnology and pharmaceutical companies.
